REXTOVY
Live / Registered — Registered (as of 15 Jul 2025)
What this means for you
Registered since 15 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97820173
- Registration number
- 7868561
- Mark type
- Stylized text
- Filed
- 02 Mar 2023
- Published for opposition
- 18 Jul 2023
- Registered
- 15 Jul 2025
- Attorney of record
- Bethany J. Whelan
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists administered only by nasal spray; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose administered only by nasal spray; Intranasal drug delivery devices, injector devices for nasal delivery, or devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose
Owner
- AMPHASTAR PHARMACEUTICALS, INC., Rancho Cucamonga, CA, US
- AMPHASTAR PHARMACEUTICALS, INC., Rancho Cucamonga, CA, US
- AMPHASTAR PHARMACEUTICALS, INC., Rancho Cucamonga, CA, US
Prosecution history
- 15 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jun 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 06 May 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 06 May 2025 — FINAL REFUSAL E-MAILED
- 06 May 2025 — SU - FINAL REFUSAL - WRITTEN
- 14 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2024 — SOU EXTENSION 1 GRANTED
- 08 Oct 2024 — SOU EXTENSION 1 FILED
- 08 Oct 2024 — SOU TEAS EXTENSION RECEIVED